Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Shih‐Jer Hsu"'
Autor:
Kai-Chun Chang, Tung-Hung Su, Sih-Han Liao, Tai-Chung Tseng, Shang-Chin Huang, Shih-Jer Hsu, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 8, Pp 891-898 (2024)
Background: Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) reduce the risk of hepatocellular carcinoma (HCC) in patients of hepatitis B. This study compared the difference between ETV and TDF on risk of HCC recurrence and mortality in patien
Externí odkaz:
https://doaj.org/article/7edb9804012a43ae9c13ddf3a667c2b3
Autor:
Chih-Horng Wu, Ming-Chih Ho, Jia-Horng Kao, Cheng-Maw Ho, Tung-Hung Su, Shih-Jer Hsu, Hsiang-Yun Huang, Chun-Yu Lin, Po-Chin Liang
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 8, Pp 747-756 (2023)
Background: Sarcopenia is a common finding in patients with decompensated cirrhosis without effective therapy. We aimed to examine whether a transjugular portosystemic shunt (TIPS) could improve the abdominal muscle mass assessed by cross-sectional i
Externí odkaz:
https://doaj.org/article/a722a11822514ff9977672c45c9ddc4e
Autor:
Meng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, Wei-Kai Wu, Shih-Jer Hsu, Tai-Chung Tseng, Sih-Han Liao, Chun-Ming Hong, Hung-Chih Yang, Chun-Jen Liu, Ming-Shiang Wu, Jia-Horng Kao
Publikováno v:
Gut Pathogens, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background Hepatitis B virus (HBV) causes chronic hepatitis B (CHB), liver cirrhosis, and hepatocellular carcinoma. The evolution of human gut microbiota during the progression of HBV-related liver diseases remains unclear. Therefore, we pro
Externí odkaz:
https://doaj.org/article/30df2698b5ed478e80793f1d36f0b497
Autor:
Meng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, Wei-Kai Wu, Shih-Jer Hsu, Tai-Chung Tseng, Sih-Han Liao, Chun-Ming Hong, Hung-Chih Yang, Chun-Jen Liu, Ming-Shiang Wu, Jia-Horng Kao
Publikováno v:
Gut Pathogens, Vol 15, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/d88046a3925143fea8e8f7a944cd2eca
Autor:
Hsien‐Hong Lin, Shih‐Jer Hsu, Sheng‐Nan Lu, Wan‐Long Chuang, Chao‐Wei Hsu, Rong‐Nan Chien, Sien‐Sing Yang, Wei‐Wen Su, Jaw‐Ching Wu, Tzong‐Hsi Lee, Cheng‐Yuan Peng, Kuan‐Chiao Tseng, Albert Qin, Yi‐Wen Huang, Pei‐Jer Chen
Publikováno v:
JGH Open, Vol 5, Iss 8, Pp 929-940 (2021)
ABSTRACT Background and Aim Ropeginterferon alfa‐2b (P1101) is a novel long‐acting mono‐PEGylated recombinant proline interferon (IFN) conjugated to a 40 kDa branched polyethylene glycol (PEG) chain at its N‐terminus, allowing every‐two‐w
Externí odkaz:
https://doaj.org/article/d99d520d83e548769c19cb86c1436144
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 2, Pp 451-453 (2022)
Externí odkaz:
https://doaj.org/article/68eec5f8281348f6bced23022623f0d6
Publikováno v:
Clinical and Molecular Hepatology, Vol 27, Iss 2, Pp 305-312 (2021)
Background/Aims The core needle biopsy (CNB), fine needle aspiration cytology (FNAC) and touch imprint cytology (TIC) are commonly used tools for the diagnosis of hepatic malignancies. However, little is known about the benefits and criteria for sele
Externí odkaz:
https://doaj.org/article/0aff144b525a47b0a77853d402aa7215
Autor:
Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, Cheng-Yuan Peng, Rong-Nan Chien, Hsien-Hong Lin, Gin-Ho Lo, Wei-Wen Su, Hsing-Tao Kuo, Chao-Wei Hsu, Sien-Sing Yang, Sheng-Shun Yang, Kuan-Chiao Tseng, Albert Qin, Yi-Wen Huang, Wan-Long Chuang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 3, Pp 956-964 (2021)
Background: Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major form as opposed to the 8 to 14 isomers of other on-market pegylated interferon products, allowing every-two-week injection with high tolerability. It rec
Externí odkaz:
https://doaj.org/article/4401340d479a46a9a34dc86614b2c302
Autor:
Chian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
Liver Cancer, p 1 (2023)
Introduction: Optimal treatment of hepatocellular carcinoma (HCC) beyond the Milan criteria is in debate. We aimed to identify candidates for surgical resection (SR) in Barcelona Clinic Liver Cancer (BCLC) –A/B HCC beyond the Milan criteria with su
Externí odkaz:
https://doaj.org/article/ee79b781a9a947418047f504358a9fc7
Autor:
Shih-Jer Hsu, Sukhee Enkhzaya, You-Yu Lin, Tai-Chung Tseng, Tulgaa Khosbayar, Cheng-Hsueh Tsai, Tzu-San Wang, Damba Enkhtuya, Dogsom Ivshinkhorol, Nyamsuren Naranzul, Badarch Jargalsaikhan, Jazag Amarsanaa, Oidov Baatarkhuu, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 3, Pp 712-719 (2020)
Background: Mongolia has the highest prevalence of hepatitis C virus (HCV) infection worldwide. Ledipasvir/sofosbuvir (LDV/SOF) was introduced to Mongolia since 2016 for HCV eradication. It has been reported that HCV resistance-associated substitutio
Externí odkaz:
https://doaj.org/article/eb0f8e67cd624b269ea711901c280070